447.22
-6.66
(-1.47%)
At close: January 10 at 1:54:18 PM CST
Research Analysis
Earnings Estimate
| Currency in USD | Current Qtr. (Dec 2024) | Next Qtr. (Mar 2025) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| No. of Analysts | -- | -- | -- | -- |
| Avg. Estimate | 0 | 0 | 0 | 0 |
| Low Estimate | 0 | 0 | 0 | 0 |
| High Estimate | 0 | 0 | 0 | 0 |
| Year Ago EPS | -- | -- | -- | -- |
Revenue Estimate
| Currency in USD | Current Qtr. (Dec 2024) | Next Qtr. (Mar 2025) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| No. of Analysts | 17 | 9 | 25 | 25 |
| Avg. Estimate | 31.95B | 30.45B | 122.1B | 123.69B |
| Low Estimate | 31.43B | 30.2B | 121.47B | 121.96B |
| High Estimate | 32.3B | 30.65B | 123.53B | 127.29B |
| Year Ago Sales | 32.02B | 30.03B | 122.43B | 122.1B |
| Sales Growth (year/est) | -0.23% | 1.42% | -0.27% | 1.30% |
EPS Trend
| Currency in USD | Current Qtr. (Dec 2024) | Next Qtr. (Mar 2025) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| Current Estimate | 0 | 0 | 0 | 0 |
| 7 Days Ago | 0 | 0 | 0 | 0 |
| 30 Days Ago | 0 | 0 | 0 | 0 |
| 60 Days Ago | 0 | 0 | 0 | 0 |
| 90 Days Ago | 0 | 0 | 0 | 0 |
EPS Revisions
| Currency in USD | Current Qtr. (Dec 2024) | Next Qtr. (Mar 2025) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| Up Last 7 Days | -- | -- | -- | -- |
| Up Last 30 Days | -- | -- | -- | -- |
| Down Last 7 Days | -- | -- | -- | -- |
| Down Last 30 Days | -- | -- | -- | -- |
Growth Estimates
| Current Qtr. | Next Qtr. | Current Year | Next Year | |
|---|---|---|---|---|
| T.MX | -- | -- | -- | -- |
| S&P 500 | 8.66% | 11.51% | 14.05% | 13.39% |
Upgrades & Downgrades
| Upgrade | RBC Capital: Sector Perform to Outperform | 1/6/2025 |
| Maintains | UBS: Buy to Buy | 12/19/2024 |
| Maintains | Goldman Sachs: Buy to Buy | 12/5/2024 |
| Maintains | Citigroup: Buy to Buy | 12/4/2024 |
| Maintains | Oppenheimer: Outperform to Outperform | 12/4/2024 |
| Maintains | Barclays: Overweight to Overweight | 12/4/2024 |